topeesp.gif (5672 bytes)

[ Index ]

CORONARY- PCVC List name

Messages

Go to #: 80

#80 De:  Jorge Did Nunez <jdid@infomed.sld.cu>
Enviado:
Mie, 15 Mar 2000 22:42
Asunto: Coronary heart disease:Guidelines / Cardiopatia coronaria:Directivas clinicas
Estimados colegas.
Estoy trasmitiendole una informacion que espero pueda ser de utilidad para
todos.
.....En la misma semana que el gobierno ha dado a conocer la Estructura del Servicio Nacional (National Service Framework)
para abordar las cardiopatias coronarias, el British Medical Journal, BMJ, publica una serie de articulos sobre la evaluacion de los
riesgos del paciente de desarrollar cardiopatias coronarias. En un editorial, Rod Jackson, profesor de epidemiologia en el Departamento
de Salud Comunitaria de la Universidad de Auckland, apoya las directivas clinicas britanicas que establecen que se debe dar prioridad
para el tratamiento a los pacientes con riesgo absoluto elevado de padecer una cardiopatia coronaria, en lugar de centrarse en los
factores de riesgo individuales......  Los detalles se pueden encontrar en http://www.bmj.com/cgi/content/full/320/7236/659
(Guidelines on preventing cardiovascular disease in clinical practice)
Un cordial saludo a todos.

Dear colleagues:
I am sending this information to you, hoping that it may turn out useful for
everyone.
....In the same week that the government has announced the National Service Framework to approach coronary heart diseases, the
British Medical Journal, BMJ, published a series of articles about evaluation of risks of the patient for developing coronary heart
disease. In his editorial, Rod Jackson, professor of epidemiology at the Department of Communal Health from the University of Auckland,
supports British clinical guidelines that establish that priority must be given to the treatment for patients with high absolute
risk of suffering coronary heart disease, instead of centering in individual risk factors...  Details are available at: http://www.bmj.com/cgi/content/full/320/7236/659
(Guidelines on preventing cardiovascular disease in clinical practice)
Kind regards for everyone,
Dr. Jorge Did, La Habana. CUBA.

Top


CETIFAC
Bioengineering
UNER

Update
Mar/29/2000